-
Fratev F, 2020: The N501Y and K417N mutations in the spike protein of SARS-CoV-2 alter the interactions with both hACE2 and human derived antibody: a free energy of perturbation study[J]. BioRxiv, , -. doi: 10.1101/2020.12.23.424283:2020.2012.2023.424283
-
Li Q, Nie J, Wu J, Zhang L, Ding R, Wang H, Zhang Y, Li T, Liu S, Zhang M, Zhao C, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Liu J, Liang H, Shi Y, Shen Y, Xie L, Zhang L, Qu X, Xu W, Huang W, Wang Y, 2021: SARS-CoV-2 501Y. V2 variants lack higher infectivity but do have immune escape[J]. Cell, 184, 2362-2371. doi: 10.1016/j.cell.2021.02.042
-
Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, Ku Z, An Z, Scharton D, Schindewolf C, Menachery VD, Shi PY, Weaver SC, 2021: The N501Y spike substitution enhances SARS-CoV-2 transmission[J]. BioRxiv, , -. doi: 10.1101/2021.03.08.434499
-
Lv Z, Deng YQ, Ye Q, Cao L, Sun CY, Fan C, Huang W, Sun S, Sun Y, Zhu L, Chen Q, Wang N, Nie J, Cui Z, Zhu D, Shaw N, Li XF, Li Q, Xie L, Wang Y, Rao Z, Qin CF, Wang X, 2020: Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody[J]. Science, 369, 1505-1509. doi: 10.1126/science.abc5881
-
Singh A, Singh RS, Sarma P, Batra G, Joshi R, Kaur H, Sharma AR, Prakash A, Medhi B, 2020: A comprehensive review of animal models for coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV[J]. Virol Sin, 35, 290-304. doi: 10.1007/s12250-020-00252-z
-
Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC, King NP, Veesler D, Bloom JD, 2020: Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding[J]. Cell, 182, 1295-1310. doi: 10.1016/j.cell.2020.08.012
-
Sun SH, Chen Q, Gu HJ, Yang G, Wang YX, Huang XY, Liu SS, Zhang NN, Li XF, Xiong R, Guo Y, Deng YQ, Huang WJ, Liu Q, Liu QM, Shen YL, Zhou Y, Yang X, Zhao TY, Fan CF, Zhou YS, Qin CF, Wang YC, 2020: A mouse model of SARS-CoV-2 infection and pathogenesis[J]. Cell Host Microbe, 28, 124-133. doi: 10.1016/j.chom.2020.05.020
-
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, Mlisana K, von Gottberg A, Walaza S, Allam M, Ismail A, Mohale T, Glass AJ, Engelbrecht S, Van Zyl G, Preiser W, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao NY, Korsman S, Davies MA, Tyers L, Mudau I, York D, Maslo C, Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, Lourenco J, Alcantara LCJ, Kosakovsky Pond SL, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T, 2021: Detection of a SARS-CoV-2 variant of concern in South Africa[J]. Nature, 592, 438-443. doi: 10.1038/s41586-021-03402-9
-
Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, Shapiro L, Sheng Z, Huang Y, Ho DD, 2021: Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7[J]. Nature, 593, 130-135. doi: 10.1038/s41586-021-03398-2
-
Ye Q, Zhou J, He Q, Li RT, Yang G, Zhang Y, Wu SJ, Chen Q, Shi JH, Zhang RR, Zhu HM, Qiu HY, Zhang T, Deng YQ, Li XF, Liu JF, Xu P, Yang X, Qin CF, 2021: SARS-CoV-2 infection in the mouse olfactory system[J]. Cell Discov, 7, 49-.
-
Zhu L, Deng Y-Q, Zhang R-R, Cui Z, Sun C-Y, Fan C-F, Xing X, Huang W, Chen Q, Zhang N-N, Ye Q, Cao T-S, Wang N, Wang L, Cao L, Wang H, Kong D, Ma J, Luo C, Zhang Y, Nie J, Sun Y, Lv Z, Shaw N, Li Q, Li X-F, Hu J, Xie L, Rao Z, Wang Y, Wang X, Qin C-F, 2020: Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2[J]. Nat Sci Rev, 8, nwaa297-.